Reducing Hyperoxia Exposure in Infants Requiring Veno-Arterial Extracorporeal Membrane Oxygenation after Cardiac Surgery
Recent studies have suggested worse outcomes in patients exposed to hyperoxia while supported on veno-arterial extracorporeal membrane oxygenation (VA-ECMO). However, there are no data regarding the effect of reducing hyperoxia exposure in this population by adjusting the fraction of inspired oxygen...
Saved in:
Published in | Pediatric cardiology Vol. 45; no. 1; pp. 143 - 149 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.01.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Recent studies have suggested worse outcomes in patients exposed to hyperoxia while supported on veno-arterial extracorporeal membrane oxygenation (VA-ECMO). However, there are no data regarding the effect of reducing hyperoxia exposure in this population by adjusting the fraction of inspired oxygen (FiO
2
) of the sweep gas of the ECMO circuit. A retrospective review of 143 patients less than 1 year of age requiring VA-ECMO following cardiac surgery from 2007 to 2018 was completed. 64 patients had a FiO
2
of the sweep gas < 100% with an average PaO
2
of 210 mm Hg in the first 48 h of support [vs 405 mm Hg in the group with a FiO
2
= 100% (p < 0.0001)]. There was no difference in mortality at 30 days after surgery or other markers of end-organ injury with respect to whether the FiO
2
was adjusted. At least one PaO
2
value < 200 mm Hg in the first 24 h on ECMO in patients with a FiO
2
< 100% trended toward a significant association (OR = 0.45, 95% CI = 0.21–1.01) with decreased risk of 30-day mortality when compared to those patients with a FiO
2
= 100% and all PaO
2
values > 200 mm Hg. Only 47% of patients with a FiO
2
< 100% had an average PaO
2
less than 200 mm Hg which indicates that the intervention of reducing the FiO
2
of the sweep gas was not entirely effective at reducing hyperoxia exposure. Future research is needed for developing clinical protocols to avoid hyperoxia and to identify mechanisms for hyperoxia-induced injury on VA-ECMO. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0172-0643 1432-1971 |
DOI: | 10.1007/s00246-023-03277-9 |